Leading associations of the pharmaceutical industry identified risks to drug provision due to a radical change in T&T concept
December 18, 2018, Moscow – The pharmaceutical industry professional associations called for maintaining the technical conditions for implementing the project for monitoring the movement of medicines within the framework of the requirements developed earlier in the pilot project. At the same time, the Association of Russian Pharmaceutical Manufacturers, the Association of International Pharmaceutical Manufacturers, the Association of Pharmaceutical Manufacturers of the Eurasian Economic Union, the APF National Association of Pharmaceutical and Medical Products Manufacturers, the Soyuzpharma Association of Pharmaceutical Institutions reaffirmed the principled commitment of their associations to the implementation of a system of labeling and traceability of medicines.
EURASIA Pharmaceutical FORUM will be held on November 20-21 in Moscow.
The event will give an overview of the recent regulatory developments in the Eurasian Union, discuss the harmonization of national regulations and the implications of recent changes for the regulatory and product approval strategies in the region, as well as facilitate an open dialogue between regulatory officials and the industry. Learn more about the market that unites Russia, Belarus, Kazakhstan, Uzbekistan, Armenia with a combined population of more than 180 million people.
7th International Forum «Clinical Trials in Russia»
150+ professionals involved in the clinical trials of pharmaceutical drugs and medical devices will meet at the 7th international Clinical Trials in Russia Forum on the 13th – 14th November in Moscow. Topical and compact 2-day programme filled with interactive formats, panel discussions and debates, showcasing original viewpoints and innovative studies.
Introducing company interests, on which share it is necessary about 80 % made and sold in the world of pharmaceutical production and the medical equipment, AIPM considers as the priority cooperation with the Russian bodies of public health services, and also with legislative and executive branches of the power, for the purpose of working out of the program of creation of favorable conditions for sale and-or production of the international pharmaceutical companies in territory of the Russian Federation